AbbVie: "Strong Buy" On Rinvoq Expansions And Immunology Pipeline Addition

I rate AbbVie stock as a Strong Buy, based on its FDA approval of Rinvoq. Read the latest analysis on the stock here.

New veteran cards could be ‘case study’ for future digital ID rollout

The introduction of digital veteran cards could provide a crucial "case study" for how such credentials operate, potentially ...
Tax Guru

ICAI SIA 220: Internal Audit Planning Standard

The case underlines that identifying all auditable units through an audit universe ensures comprehensive coverage, prevents oversight, and guides resource allocation for efficient internal ...
BusinessWorld

Thrift banks see no more need for cut in required minimum liquidity ratio

THE CHAMBER of Thrift Banks (CTB) is no longer pushing for a cut in the industry’s minimum liquidity ratio (MLR) as they now have enough liquid assets to support their lending activities. “You saw how ...

Transcript: What’s up with the US economy? With Austan Goolsbee

Chris Giles talks to Austan Goolsbee, president of the Federal Reserve Bank of Chicago and voter on the central bank’s ...